Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ANXA1 |
| Upstream (Parents) |
|---|
| (<<) PLAU → ANXA1 |
| (<<) CAPG → ANXA1 |
| (<<) EMP1 → ANXA1 |
| (<<) PMP22 → ANXA1 |
| (<<) TUBB6 → ANXA1 |
| Downstream (Children) |
|---|
| ANXA1 → SPRR1A (>>) |
| ANXA1 → KRT6A (>>) |
| ANXA1 → SPRR3 (>>) |
| ANXA1 → SPRR1B (>>) |
| ANXA1 → MMP10 (>>) |
| ANXA1 → CST6 (>>) |
| ANXA1 → MUC16 (>>) |
| ANXA1 → F3 (>>) |
| ANXA1 → MGC13053 (>>) |
| ANXA1 → CC2D1A (>>) |
| ANXA1 → NDP (>>) |
| ANXA1 → PCSK5 (>>) |
| ANXA1 → OGFR (>>) |
| ANXA1 → HSPA2 (>>) |
| ANXA1 → GNA15 (>>) |
| ANXA1 → WBP5 (>>) |
| ANXA1 → JAK2 (>>) |
| ANXA1 → WARS (>>) |
| ANXA1 → CHN2 (>>) |
